Skip to main navigation Skip to search Skip to main content

cellSTAAR: incorporating single-cell-sequencing-based functional data to boost power in rare variant association testing of noncoding regions

  • NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
  • Harvard University
  • Duke University
  • University of North Carolina at Chapel Hill
  • Massachusetts General Hospital
  • The Broad Institute of MIT and Harvard
  • Northeast Normal University
  • Wake Forest University
  • University of South Carolina
  • University of Texas Rio Grande Valley
  • University of Texas Health Science Center at Houston
  • Baylor College of Medicine
  • Brigham and Women’s Hospital
  • University of Pittsburgh
  • University of Mississippi
  • The Lundquist Institute
  • Washington University St. Louis
  • Tulane University
  • Boston University
  • Framingham Heart Study
  • Northwestern University
  • Triservice General Hospital Taiwan
  • Tri-Service General Hospital National Defense Medical Center
  • Johns Hopkins University
  • University of Michigan, Ann Arbor
  • Icahn School of Medicine at Mount Sinai
  • Fred Hutchinson Cancer Research Center
  • University of Colorado Anschutz Medical Campus
  • Brown University
  • University of Copenhagen
  • University of Virginia
  • George Washington University
  • National Institutes of Health
  • University of Maryland, Baltimore
  • Naseri & Associates Public Health Consultancy Firm and Family Health Clinic
  • University of Washington

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Understanding how rare genetic variants influence complex traits remains a major challenge, particularly when these variants lie in noncoding regions of the genome. The effects of variants within candidate cis-regulatory elements (cCREs) often depend on the cell type, making interpretation difficult. Here we introduce cellSTAAR, which integrates whole-genome sequencing data with single-cell assay for transposase-accessible chromatin using sequencing data to capture variability in chromatin accessibility across cell types via the construction of cell-type-specific functional annotations and regulatory elements. To reflect the uncertainty in cCRE–gene linking, cellSTAAR uses a comprehensive strategy to link cCREs to their target genes. We applied cellSTAAR to data from the Trans-Omics for Precision Medicine consortium (n ≈ 60,000) and replicated our findings using the UK Biobank (n ≈ 190,000). Across four lipid traits, cellSTAAR improved the detection of biologically meaningful associations and enhanced biological interpretability. These results demonstrate the potential of cell-type-aware approaches to boost discovery in rare variant whole-genome sequencing association studies.

Original languageEnglish
Pages (from-to)338-349
Number of pages12
JournalNature Methods
Volume23
Issue number2
DOIs
StatePublished - Feb 2026

Fingerprint

Dive into the research topics of 'cellSTAAR: incorporating single-cell-sequencing-based functional data to boost power in rare variant association testing of noncoding regions'. Together they form a unique fingerprint.

Cite this